Intravitreal anti-VEGF treatment as adjunctive treatment in the management of diabetic retinopathy
- PMID: 24329129
- DOI: 10.1089/jop.2013.0217
Intravitreal anti-VEGF treatment as adjunctive treatment in the management of diabetic retinopathy
Comment in
-
Response to Carifi et al.'s letter.J Ocul Pharmacol Ther. 2014 May;30(4):304-5. doi: 10.1089/jop.2013.0217.rs. Epub 2014 Jan 2. J Ocul Pharmacol Ther. 2014. PMID: 24383445 No abstract available.
Comment on
-
Intravitreal bevacizumab (Avastin) and panretinal photocoagulation in the treatment of high-risk proliferative diabetic retinopathy.J Ocul Pharmacol Ther. 2013 Jul-Aug;29(6):550-5. doi: 10.1089/jop.2012.0202. Epub 2013 Mar 15. J Ocul Pharmacol Ther. 2013. PMID: 23495932 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
